Adacolumn®
Adacolumn® is a medical device with 6 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 3 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
1
Late Stage
Highest Phase Reached
Phase 3Trial Status & Enrollment
100.0%
3 of 3 finished
0.0%
0 ended early
1
trials recruiting
6
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A Trial of Adacolumn on Cerebral Edema After Anterior Circulation Ischemic Stroke
National GMA Post-market Clinical Follow-up Study (GRACE)
CT to Assess the Efficacy and Safety of Adding GMA to Infliximab in Paediatric Patients With Steroid-refractory Ulcerative Colitis
ADAPT Adacolumn Pediatric Trial in Ulcerative Colitis
CESA 5.10 Investigation to Compare the Efficacy and Safety of the Adacolumn® Apheresis Device in Patients With Active Ulcerative Colitis
Clinical Trials (6)
A Trial of Adacolumn on Cerebral Edema After Anterior Circulation Ischemic Stroke
National GMA Post-market Clinical Follow-up Study (GRACE)
CT to Assess the Efficacy and Safety of Adding GMA to Infliximab in Paediatric Patients With Steroid-refractory Ulcerative Colitis
ADAPT Adacolumn Pediatric Trial in Ulcerative Colitis
CESA 5.10 Investigation to Compare the Efficacy and Safety of the Adacolumn® Apheresis Device in Patients With Active Ulcerative Colitis
Study for the Treatment of Crohn's Disease With Adacolumn
All 6 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 6